SCHEMBL6166149

SCHEMBL6166149

Cc1ccc(-c2cccc(OP(O)O)c2-c2ccc(C)cc2C(C)(C)C)c(C(C)(C)C)c1

nearest known ligand 0.33

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.33
POLB P06746 2/20 0.33
ALDH1A1 P00352 1/20 0.31
CA2 P00918 1/20 0.31
TYR P14679 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
IDO1 P14902 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8928073 0.89 MRGPRX4 (0.32) MRGPRX4POLBALDH1A1
SCHEMBL11335843 0.86 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2
SCHEMBL690037 0.84 CA2 (0.36) ALDH1A1CA2
SCHEMBL10605861 0.81 SMN1; SMN2 (0.36) POLBALDH1A1CA2TYRSMN1; SMN2
SCHEMBL131794 0.77 TDP1 (0.34) ALDH1A1CA2
SCHEMBL11101564 0.77 ALDH1A1 (0.35) POLBALDH1A1CA2TYRSMN1; SMN2
SCHEMBL10938199 0.77 ALDH1A1 (0.42) POLBALDH1A1CA2TYRSMN1; SMN2
SCHEMBL2775176 0.76 ALDH1A1 (0.41) MRGPRX4POLBALDH1A1CA2TYR
SCHEMBL20560118 0.75 PDK2 (0.34) POLBALDH1A1CA2TYRSMN1; SMN2
SCHEMBL7591489 0.75 ALDH1A1 (0.33) ALDH1A1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1312598-B1 Process for producing aldehyde MITSUBISHI CHEM CORP (JP) 2005-02-16 EP disclosed
EP-1008581-B1 Process for producing aldehyde MITSUBISHI CHEM CORP (JP) 2004-04-21 EP disclosed
US-6610891-B1 Reduces degradation or decomposition of catalyst MITSUBISHI CHEMICAL CORPORATION (JP) 2003-08-26 US disclosed
US-6583324-B2 By hydroformylation with rhodium complex catalyst containing an organic phosphite ligand; preventing catalyst poisoning by having the aldehyde remain in the catalyst solution in the separation step MITSUBISHI CHEMICAL CORPORATION (JP) 2003-06-24 US disclosed
EP-1312598-A1 Process for producing aldehyde MITSUBISHI CHEMICAL CORPORATION (JP) 2003-05-21 EP disclosed
US-20020049355-A1 Process for producing aldehyde MITSUBISHI CHEMICAL CORPORATION (JP) 2002-04-25 US disclosed
US-6291717-B1 REACTING OLEFINIC COMPOUND WITH CARBON MONOXIDE AND HYDROGEN IN THE PRESENCE OF A RHODIUM COMPLEX CATALYST COMPRISING RHODIUM AND ORGANIC PHOSPHITE IN REACTION ZONE; SEPARATING CATALYST AND ALDEHYDE; RECYCLING CATALYST SOLUTION MITSUBISHI CHEMICAL CORPORATION (JP) 2001-09-18 US disclosed
EP-1008581-A1 Process for producing aldehyde MITSUBISHI CHEMICAL CORPORATION (JP) 2000-06-14 EP disclosed
US-5672766-A REACTING OLEFIN WITH CARBON MONOXIDE AND HYDROGEN IN THE PRESENCE OF A RHODIUM COMPLEX CATALYST MITSUBISHI CHEMICAL CORPORATION (JP) 1997-09-30 US disclosed
US-5648554-A GROUP 8 METAL PHOSPHITE COMPLEX CATALYST MITSUBISHI CHEMICAL CORPORATION (JP) 1997-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020049355-A1 Process for producing aldehyde ALDH2, OGDH, HAO2 MRGPRX4 3597/4885POLB 705/4885ALDH1A1 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.